4.88
3.56%
-0.18
Dopo l'orario di chiusura:
4.92
0.04
+0.82%
Exscientia Plc Adr Borsa (EXAI) Ultime notizie
Exscientia Plc ADR (EXAI)’s Market Momentum: Closing Strong at 5.06, Down -4.53 - The Dwinnex
Taking on analysts’ expectations and winning: Exscientia Plc ADR (EXAI) - SETE News
Exscientia's SWOT analysis: AI biotech stock faces merger, pipeline milestones - Investing.com
Exscientia Plc ADR (EXAI) expanding its growth trajectory ahead - SETE News
A stock that deserves closer examination: Exscientia Plc ADR (EXAI) - US Post News
Take off with Exscientia Plc ADR (EXAI): Get ready for trading - SETE News
Exscientia Plc ADR (EXAI)’s stock chart: A technical perspective - US Post News
Market Insights: Exscientia Plc ADR (EXAI)’s Notable Gain of 3.78, Closing at 5.22 - The Dwinnex
EXAI’s 52-Week Rollercoaster: From $3.80 to $7.91 – What’s Next for Investors? - The InvestChronicle
Closing Figures Unveiled: Exscientia Plc ADR (EXAI) Drop -1.02, Closes at 4.85 - The Dwinnex
EXAI (Exscientia Plc ADR) has impressive results - US Post News
Check out these key findings about Exscientia Plc ADR (EXAI) - SETE News
Exscientia Plc ADR (EXAI) Stock: A Year of Market Fluctuations - The InvestChronicle
Are Investors Keen On Selling Holdings In N2OFF Inc. (NASDAQ: NITO)? - Stocks Register
Daily Market Movement: Exscientia Plc ADR (EXAI) Sees a -1.77 Decrease, Closing at 5.56 - The Dwinnex
Ratios Reveal: Breaking Down Exscientia Plc ADR (EXAI)’s Financial Health - The Dwinnex
AI in Pharma and Biotech Market Projected Growth at 18.8% CAGR to Reach USD 13.1 billion by 2034 | Exclusive Research Report by Transparency Market Research Inc. - GlobeNewswire Inc.
Exscientia to Present at the Morgan Stanley 22 nd Annual Global Healthcare Conference - TT Nyhetsbyrån
Recursion Pharmaceuticals secures key shareholder support - Investing.com
What technical indicators reveal about EXAI stock - US Post News
Deeper Dive: Understanding Exscientia Plc ADR (EXAI) Through its Various Ratios - The Dwinnex
Have you been able to find a good deal on Exscientia Plc ADR’s shares? - US Post News
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why. - The Motley Fool
Exscientia Plc ADR (EXAI) Is Worth Accumulating At Current Levels - Stocks Register
EXAI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Market Resilience: Exscientia Plc ADR (EXAI) Finishes Strong at 5.00, Up 2.88 - The Dwinnex
Taking the lead: Exscientia Plc ADR (EXAI) - SETE News
Examining Exscientia Plc ADR (EXAI) stock is warranted - US Post News
Before Buying Exscientia Plc ADR (NASDAQ: EXAI) Stock, Read This First - Stocks Register
Exscientia stock downgraded to Hold amid Recursion merger - Investing.com
Recursion and Exscientia announce merger to enhance drug discovery - Investing.com
Recursion and Exscientia announce merger to enhance drug discovery - Investing.com India
Views of Wall Street’s Leading Experts on Exscientia Plc ADR - SETE News
EXAI’s Debt-to-Equity Ratio at 0.06: What It Means for Exscientia Plc ADR’s Future - The InvestChronicle
Amazon (AMZN) Plunges 19.1% in a Month: Should You Buy the Dip? - Zacks Investment Research
Market Momentum: Exscientia Plc ADR (EXAI) Registers a -8.19 Decrease, Closing at 4.26 - The Dwinnex
Analyzing the Impact of Earnings Reports on Vivid Seats Inc Inc. (SEAT) Price Performance - The InvestChronicle
Exscientia Plc ADR (EXAI) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
A Deep Dive into Clear Channel Outdoor Holdings Inc. (CCO) Stock Performance - The InvestChronicle
Investor’s Toolkit: Key Ratios for Assessing Exscientia Plc ADR (EXAI)’s Performance - The Dwinnex
How to interpret Exscientia Plc ADR (EXAI)’s stock chart patterns - US Post News
Balance Sheet Insights: Exscientia Plc ADR (EXAI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Exscientia gets buy rating, positive on asset control and trial plans - Investing.com
Exscientia takes full control of cancer drug program - Investing.com
The Exscientia Plc ADR (EXAI) had a good session last reading, didn’t it? - US Post News
This trade activity should not be overlooked: Exscientia Plc ADR (EXAI) - SETE News
Amazon (AMZN) Expands AWS Clientele With Exscientia Deal - Yahoo Finance
Financial Analysis: Exscientia Plc ADR (EXAI)’s Ratios Unveil Key Insights - The Dwinnex
Exscientia Plc ADR: Weathering Stock Market Storms with 702.17M Market Cap - The InvestChronicle
AWS says it has trained millions of workers on key cloud skills for free - Yahoo Singapore News
Exscientia expands AI drug discovery with AWS - Investing.com
Royal Gold share target up, keeps Outperform rating on strong Q2 sales By Investing.com - Investing.com India
International Media Acquisition Corp. announces board reshuffle By Investing.com - Investing.com South Africa
Exscientia stock gets Buy rating from TD Cowen on AI-driven platform - Investing.com
How Much Upside is Left in Exscientia (EXAI)? Wall Street Analysts Think 61.43% - Yahoo News Malaysia
Is Exscientia Plc ADR (EXAI) a opportunity to investors? – US Post News - US Post News
Wall Street Analysts Think Exscientia PLC Sponsored ADR (EXAI) Could Surge 63%: Read This Before Placing a Bet - Yahoo New Zealand News
Exscientia Plc ADR (EXAI) is looking forward to a strong quarter – Sete News - SETE News
How Much Upside is Left in Exscientia (EXAI)? Wall Street Analysts Think 61.43% - MSN
How Much Upside is Left in Exscientia (EXAI)? Wall Street Analysts Think 61.43% - Yahoo Finance
Exscientia Plc ADR (EXAI) stock on the rise: An overview – US Post News - US Post News
Exscientia Plc ADR’s Shares Reel: -23.79% Quarterly Revenue Decline Amid 635.24M Market Cap - The InvestChronicle
Exscientia Plc ADR (EXAI) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Aziyo Biologics, Inc. (AZYO) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Lifestyle Australia
Exscientia bolsters leadership with tech and clinical experts By Investing.com - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):